As melphalan is used for anti-cancer chemotherapy in patients with retinoblastoma, Hosoya et al. (2008) investigated the LAT1 binding of melphalan and other synthetic amino acid-conjugated mustards in LAT1 expressing conditionally immortalized rat retinal endothelial TR-iBRB2 cells (85). Here, SLC7A5 is linked to cancer.